#JPM22: High­lights for the year ahead in on­col­o­gy R&D — What's hot, what's not?

Across the broad spec­trum of on­col­o­gy drug de­vel­op­ment, 2021 marked a year of break­throughs with off-the-shelf cell ther­a­pies com­ing in­to their own (with some ques­tions) …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER